← Leaderboards
Ronald Zolty
University Of Colorado Denver
$374,272
Attributed
$374,272
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $169K · FY2005–08$200K$150K$100K$50K$0
'05
'06
'07
'08
Funding mix
By agency
NIH$374,272 · 4
By mechanism
M01$374,272 · 4
Top collaborators
No co-investigators on record.
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Michael R. Bristow$7,111,960
- Mark L Dell'acqua$24,552,179
- Thomas C Rich$7,525,940
- Jonathan David Port$3,288,322
- Paula C Bickford$5,784,723
Others in their field
Top investigators on “Adrenergic”
- Scott T Weiss · University Of California, San Diego$33,700,479
- Walter J Koch · Duke University$26,804,343
- Brian K Kobilka · Stanford University$21,509,981
- Charles W. Gorodetzky · Us Worldmeds, Llc$20,848,803
- Howard A Rockman · University Of California San Diego$19,177,720
- Bruce M Psaty · University Of Washington$17,027,178
Research focus
AdrenergicAdrenergic AgentsAdrenergic Beta-AntagonistsAdrenergic ReceptorCardiomyopathiesComputer Retrieval Of Information On Scientific Projects DatabaseControlled Clinical Trials, RandomizedEconomic BurdenEfracFailure (Biologic Function)FundingGeneticGrantHeartHeart FailureHeart Failure, CongestiveHigh PrevalenceHomeostasisHospital Admission RateInstitutionMaintenanceMeasurableMortality Vital StatisticsPlay
Grant awards (4)
BETAADRENERGICRECEPTORPOLYMORPHISMS,&RSPNS TO BETABLOCKERTHERAPY,IN HRT FAILURE$8,780
M01 · FY2008 · RR · contact PI
BETAADRENERGICRECEPTORPOLYMORPHISMS,&RSPNS TO BETABLOCKERTHERAPY,IN HRT FAILURE$74,730
M01 · FY2007 · RR · contact PI
BETAADRENERGICRECEPTORPOLYMORPHISMS,&RSPNS TO BETABLOCKERTHERAPY,IN HRT FAILURE$168,952
M01 · FY2006 · RR · contact PI
BETAADRENERGICRECEPTORPOLYMORPHISMS,&RSPNS TO BETABLOCKERTHERAPY,IN HRT FAILURE$121,810
M01 · FY2005 · RR